Deletion of Von Willebrand A Domain Containing Protein (VWA8) raises activity of mitochondrial electron transport chain complexes in hepatocytes.

ADP, adenine dinucleotide phosphate ANT, adenine nucleotide translocase ATP, adenine trinucleotide phosphate ETC, electron transport chain Electron transport chain HNF4, hepatocyte nuclear factor 4 Hepatocytes Mitochondria NADPH, nicotinamide adenine dinucleotide phosphate OCR, oxygen consumption rate PFO, perfringolysin ROS, reactive oxygen species TMHQ, Tetramethylhydroquinone TMPD, N,N,N′,N'-Tetramethyl-p-phenylenediamine VWA8 VWA8, Von Willebrand Domain-containing Protein 8

Journal

Biochemistry and biophysics reports
ISSN: 2405-5808
Titre abrégé: Biochem Biophys Rep
Pays: Netherlands
ID NLM: 101660999

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 19 08 2020
revised: 19 01 2021
accepted: 19 01 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 6 3 2021
Statut: epublish

Résumé

VWA8 (Von Willebrand A Domain Containing Protein 8) is a AAA+ ATPase that is localized to the mitochondrial matrix and is widely expressed in highly energetic tissues. Originally found to be higher in abundance in livers of mice fed a high fat diet, deletion of the VWA8 gene in differentiated mouse AML12 hepatocytes unexpectedly produced a phenotype of higher mitochondrial and nonmitochondrial oxidative metabolism, higher ROS (reactive oxygen species) production mainly from NADPH oxidases, and increased HNF4a expression. The purposes of this study were first, to determine whether higher mitochondrial oxidative capacity in VWA8 null hepatocytes is the product of higher capacity in all aspects of the electron transport chain and oxidative phosphorylation, and second, the density of cristae in mitochondria and mitochondrial content was measured to determine if higher mitochondrial oxidative capacity is accompanied by greater cristae area and mitochondrial abundance. Electron transport chain complexes I, II, III, and IV activities all were higher in hepatocytes in which the VWA8 gene had been deleted using CRISPR/Cas9. A comparison of abundance of proteins in electron transport chain complexes I, III and ATP synthase previously determined using an unbiased proteomics approach in hepatocytes in which VWA8 had been deleted showed agreement with the activity assays. Mitochondrial cristae, the site where electron transport chain complexes are located, were quantified using electron microscopy and stereology. Cristae density, per mitochondrial area, was almost two-fold higher in the VWA8 null cells (P < 0.01), and mitochondrial area was two-fold higher in the VWA8 null cells (P < 0.05). The results of this study allow us to conclude that despite sustained, higher ROS production in VWA8 null cells, a global mitochondrial compensatory response was maintained, resulting in overall higher mitochondrial oxidative capacity.

Identifiants

pubmed: 33665377
doi: 10.1016/j.bbrep.2021.100928
pii: S2405-5808(21)00022-4
pmc: PMC7900673
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100928

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES006694
Pays : United States

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Physiol. 2017 May 1;595(9):2839-2847
pubmed: 27696420
Biochem Biophys Res Commun. 2020 Jan 1;521(1):158-163
pubmed: 31630795
J Electron Microsc Tech. 1988 Sep;10(1):77-85
pubmed: 3193245
Biochim Biophys Acta. 1999 Feb 4;1417(1):16-24
pubmed: 10076031
J Biol Chem. 2017 Apr 28;292(17):7189-7207
pubmed: 28270511
Nat Protoc. 2014 Feb;9(2):421-38
pubmed: 24457333
Biochem Biophys Res Commun. 2017 Jun 3;487(3):545-551
pubmed: 28414126
Biochemistry. 2019 Dec 10;58(49):4983-4996
pubmed: 31702900

Auteurs

Moulun Luo (M)

Department of Medicine, Division of Endocrinology, USA.

Wuqiong Ma (W)

Department of Medicine, Division of Endocrinology, USA.

Rocio Zapata-Bustos (R)

Department of Medicine, Division of Endocrinology, USA.

Wayne T Willis (WT)

Department of Medicine, Division of Endocrinology, USA.
Center for Disparities in Diabetes, Obesity, and Metabolism, The University of Arizona, Tucson, AZ, 85724, USA.

Lawrence J Mandarino (LJ)

Department of Medicine, Division of Endocrinology, USA.
Center for Disparities in Diabetes, Obesity, and Metabolism, The University of Arizona, Tucson, AZ, 85724, USA.

Classifications MeSH